What is Radiaction?
Radiaction Medical specializes in developing cutting-edge radiation protection technology designed to block scatter radiation at its source, thereby enhancing the safety of interventional medical teams. Their primary offering, the Radiaction Smart Shield, functions as a dynamic barrier, improving workflow efficiency and protecting healthcare personnel during procedures. By addressing the health hazards of ionizing radiation, the company aims to increase procedural capacity and boost productivity within clinical environments. Radiaction's solutions are recognized and trusted by medical experts across various healthcare settings.
How much funding has Radiaction raised?
Radiaction has raised a total of $30.6M across 2 funding rounds:
Unspecified
$18M
Series C
$12.6M
Unspecified (2020): $18M with participation from InnovaHealth Partners LP
Series C (2023): $12.6M led by InnovaHealth Partners
Key Investors in Radiaction
InnovaHealth Partners
InnovaHealth Partners is a New York City-based investment firm specializing in growth buyouts of established medical technology companies. The firm focuses on high-growth sectors of the medical device industry, partnering with management teams to develop innovative technologies that address significant unmet surgical needs.
What's next for Radiaction?
The recent major strategic investment signifies a pivotal moment for Radiaction, positioning the company for accelerated growth and market penetration. This substantial backing, particularly within the context of a Series C financing, suggests Radiaction is poised to scale its operations, expand its product development, and potentially broaden its reach into new medical specialties or geographical markets. The company's focus on enhancing healthcare staff safety while improving procedural efficiency aligns with the increasing demand for advanced medical technologies that support both clinical outcomes and operational productivity.
See full Radiaction company page
